# Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies

> **NCT00688519** · PHASE3 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 336 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** U0267
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT00688519
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 336 (ACTUAL)
- **Last updated:** 2017-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00688519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00688519, "Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00688519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*